articleNew England Journal of MedicineJan 23, 2008BRONZE OA

HLA-Mismatched Renal Transplantation without Maintenance Immunosuppression

Harvard University · Massachusetts General Hospital · +3 more institutions

PubMed
Indexed incrossrefpubmed

Abstract

Five patients with end-stage renal disease received combined bone marrow and kidney transplants from HLA single-haplotype mismatched living related donors, with the use of a nonmyeloablative preparative regimen. Transient chimerism and reversible capillary leak syndrome developed in all recipients. Irreversible humoral rejection occurred in one patient. In the other four recipients, it was possible to discontinue all immunosuppressive therapy 9 to 14 months after the transplantation, and renal function has remained stable for 2.0 to 5.3 years since transplantation. The T cells from these four recipients, tested in vitro, showed donor-specific unresponsiveness and in specimens from allograft biopsies, obtained…

No related works found for this paper.

Funding